Denice Torres

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
New Hope, PA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Sam Martin, attorney-in-fact for Denice Torres
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Denice Torres

Form 4 holding Director

2seventy bio, Inc.

Security class
Stock Options (Right to buy)
Shares / value
24,100
Estimated value
$94,713
Report date
10 Jun 2024
Price
$3.93
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

GLAUKOS Corp

Security class
Stock Option (Right to Buy)
Shares / value
2,987
Estimated value
$86,348
Report date
28 May 2026
Price
$69.30
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

bluebird bio, Inc.

Security class
Common Stock
Shares / value
2,726
Estimated value
$3,897
Report date
11 Nov 2021
Price
$1.43
Ownership
Direct
Form 4 holding Director

Karuna Therapeutics, Inc.

Security class
Option (right to buy)
Shares / value
0
Estimated value
$0
Report date
18 Mar 2024
Price
$92.30
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Surface Oncology, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
24,000
Estimated value
Report date
08 Jun 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Seaport Therapeutics, Inc.

Security class
Common Stock
Shares / value
13,406
Estimated value
Report date
04 May 2026
Price
Ownership
By Denice M. Torres Revocable Trust
Form 4 holding Director

Seaport Therapeutics, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
12,258
Estimated value
Report date
30 Apr 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

2seventy bio, Inc.

Security class
Stock Options (Right to buy)
Shares / value
0
Estimated value
Report date
13 May 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

bluebird bio, Inc.

Security class
Stock Option (right to buy)
Shares / value
0
Estimated value
Report date
11 Nov 2021
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Seaport Therapeutics, Inc.

Security class
Series B Preferred Stock
Shares / value
0
Estimated value
Report date
04 May 2026
Price
Ownership
By Denice M. Torres Revocable Trust
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Denice Torres

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .